| Breakdown | Mar 2026 | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.07T | 1.07T | 1.08T | 1.14T | 943.98B |
| Gross Profit | 261.11B | 257.00B | 255.25B | 251.48B | 211.96B |
| EBITDA | 90.93B | 62.69B | 90.30B | 64.70B | 96.53B |
| Net Income | 30.94B | 7.72B | 32.74B | 7.71B | 44.05B |
Balance Sheet | |||||
| Total Assets | 1.32T | 1.26T | 1.20T | 1.15T | 1.09T |
| Cash, Cash Equivalents and Short-Term Investments | 111.07B | 111.13B | 104.46B | 97.48B | 88.78B |
| Total Debt | 262.93B | 248.28B | 171.00B | 171.74B | 111.25B |
| Total Liabilities | 634.30B | 613.83B | 573.39B | 571.95B | 528.09B |
| Stockholders Equity | 681.67B | 640.68B | 619.77B | 569.26B | 551.39B |
Cash Flow | |||||
| Free Cash Flow | 11.33B | -34.92B | 25.91B | -15.18B | -15.18B |
| Operating Cash Flow | 63.67B | 12.76B | 65.37B | 21.37B | 21.37B |
| Investing Cash Flow | -59.36B | -49.48B | -43.27B | -37.28B | -37.28B |
| Financing Cash Flow | -7.14B | 41.91B | -17.21B | 21.68B | 21.68B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥315.26B | 14.24 | ― | 1.65% | 14.49% | -21.17% | |
72 Outperform | ¥755.20B | 18.72 | 5.14% | 3.31% | -1.14% | -19.79% | |
71 Outperform | ¥545.33B | 28.49 | 5.25% | 2.13% | -2.23% | 130.96% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
60 Neutral | ¥636.53B | 18.29 | 4.83% | 2.95% | -2.67% | -85.21% | |
59 Neutral | ¥716.83B | 29.16 | 11.66% | 1.03% | 10.11% | 41.98% | |
55 Neutral | ¥631.13B | -6.48 | 1.88% | 6.16% | 1.98% | -48.28% |